erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
"we are calling for the immediate implementation of a statutory duty of candour for the health trusts."
.
.
.
one thought on “chess grandmasters show the same longevity advantage as elite athletes”
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.
. would identify hospitals that are best positioned to treat strokes and establish protocols for emergency responders handling stroke patients.
.